ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Eterna Therapeutics Inc

Eterna Therapeutics Inc (ERNA)

0,3358
-0,0042
(-1,24%)
Fermé 08 Février 10:00PM
0,3252
-0,0106
(-3,16%)
Après les heures de négociation: 1:50AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,3252
Prix Achat
0,3252
Prix Vente
0,348
Volume échangé
524 960
0,32 Fourchette du Jour 0,3666
0,2212 Plage de 52 semaines 2,625
Cap du marché
Clôture Veille
0,34
Ouverture
0,3497
Dernière Transaction
1
@
0.34
Dernière heure de transaction
Volume financier
US$ 178 548
VWAP
0,340117
Volume moyen (3 m)
12 460 696
Actions en circulation
51 374 713
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,78
Bénéfice par action (BPA)
-0,42
Chiffre d'affairess
68k
Bénéfice net
-21,68M

À propos de Eterna Therapeutics Inc

Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more

Secteur
Pharmaceutical Preparations
Industrie
Television Broadcast Station
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
2022
Eterna Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ERNA. Le dernier cours de clôture d'Eterna Therapeutics était de US$0,34. Au cours de la dernière année, les actions de Eterna Therapeutics ont été négociées dans une fourchette de prix de US$ 0,2212 à US$ 2,625.

Eterna Therapeutics compte actuellement 51 374 713 actions en circulation. La capitalisation boursière d'Eterna Therapeutics est de US$17,47 million. Eterna Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.78.

ERNA Dernières nouvelles

Eterna Therapeutics Announces Expansion of Scientific Advisory Board

CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the addition of...

Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 in Ovarian Cancer

CAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced positive results...

Eterna Therapeutics Announces Appointment of Dr. Elena Ratner to Board of Directors

CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the appointment of...

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce...

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors has authorized a stock...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0517-13.71716635710.37690.3990.3125135870.34766757CS
40.01514.869396968720.31010.960.2915345229530.46009912CS
12-0.5849-64.26766289420.91010.960.2212124606960.45062396CS
26-1.5148-82.32608695651.841.950.221254000030.4528267CS
52-1.2531-79.39555217641.57832.6250.221227043190.45529346CS
156-3.8748-92.25714285714.27.150.221211944730.52530576CS
260-3.8748-92.25714285714.27.150.221211944730.52530576CS

ERNA - Frequently Asked Questions (FAQ)

What is the current Eterna Therapeutics share price?
The current share price of Eterna Therapeutics is US$ 0,3252
How many Eterna Therapeutics shares are in issue?
Eterna Therapeutics has 51 374 713 shares in issue
What is the market cap of Eterna Therapeutics?
The market capitalisation of Eterna Therapeutics is USD 17,47M
What is the 1 year trading range for Eterna Therapeutics share price?
Eterna Therapeutics has traded in the range of US$ 0,2212 to US$ 2,625 during the past year
What is the PE ratio of Eterna Therapeutics?
The price to earnings ratio of Eterna Therapeutics is -0,78
What is the cash to sales ratio of Eterna Therapeutics?
The cash to sales ratio of Eterna Therapeutics is 253,85
What is the reporting currency for Eterna Therapeutics?
Eterna Therapeutics reports financial results in USD
What is the latest annual turnover for Eterna Therapeutics?
The latest annual turnover of Eterna Therapeutics is USD 68k
What is the latest annual profit for Eterna Therapeutics?
The latest annual profit of Eterna Therapeutics is USD -21,68M
What is the registered address of Eterna Therapeutics?
The registered address for Eterna Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Eterna Therapeutics website address?
The website address for Eterna Therapeutics is eternatx.com
Which industry sector does Eterna Therapeutics operate in?
Eterna Therapeutics operates in the TELEVISION BROADCAST STATION sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock